vix.ing · top · new · best · stats · spec

Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research

2024/11/29 by Roderich D. Süßmuth, Marcel David Kulike-Koczula, Peng Gao +1 · 1 voice · 1 citation
Computer Science · Environmental Science · Chemistry · #Computational Drug Discovery Methods #Chemistry and Chemical Engineering #Synthesis of β-Lactam Compounds

paper · pdf · doi:10.1002/anie.202414325

openalex publication_date 2024/11/29 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31

Abstract

In the fight against bacterial infections, particularly those caused by multi-resistant pathogens known as "superbugs", the need for new antibacterials is undoubted in scientific communities and is by now also widely perceived by the general population. However, the antibacterial research landscape has changed considerably over the past years. With few exceptions, the majority of big pharma companies has left the field and thus, the decline in R&D on antibacterials severely impacts the drug pipeline. In recent years, antibacterial research has increasingly relied on smaller companies or academic research institutions, which mostly have only limited financial resources, to carry a drug discovery and development process from the beginning and through to the beginning of clinical phases. This review formulates the requirements for an antibacterial in regard of targeted pathogens, resistance mechanisms and drug discovery. Strategies are shown for the discovery of new antibacterial structures originating from natural sources, by chemical synthesis and more recently from artificial intelligence approaches. This is complemented by principles for the computer-aided design of antibacterials and the refinement of a lead structure. The second part of the article comprises a compilation of antibacterial molecules classified according to bacterial target structures, e.g. cell wall synthesis, protein synthesis, as well as more recently emerging target classes, e.g. fatty acid synthesis, proteases and membrane proteins. Aspects of the origin, the antibacterial spectrum, resistance and the current development status of the presented drug molecules are highlighted.

Citations

Cited by

Discussions

Related